SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons

Commercially available immunoassays have been developed for sensitive and specific detection of antibodies against SARS-CoV-2. While a fast and reliable IgG response has been reported for samples from hospitalized COVID-19 patients, less is known about ambulatory patients. We evaluated the SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wellinghausen, Nele, Plonné, Dietmar, Voss, Meike, Ivanova, Ralitsa, Frodl, Reinhard, Deininger, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336915/
https://www.ncbi.nlm.nih.gov/pubmed/32707511
http://dx.doi.org/10.1016/j.jcv.2020.104542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336915/
https://www.ncbi.nlm.nih.gov/pubmed/32707511
http://dx.doi.org/10.1016/j.jcv.2020.104542

Ejemplares similares